| Heart Rhythm Society

2012 HRS/ACCF Expert Consensus Statement on Pacemaker Device and Mode Selection

June 26, 2012—The statement is the first of its kind to specifically address pacemaker device and mode selection, expanding upon the

2012 PACES/HRS Expert Consensus Statement on the Management of the Asymptomatic Young Patient with a Wolff-Parkinson-White (WPW, Ventricular Preexcitation) Electrocardiographic Pattern

May 10, 2012—The expert consensus statement provides first-of-its-kind clinical practice guidelines on the evaluation and management of asymptomatic young patients with a Wolff-Parkinson-White

EHRA Consensus Document on the Management of Supraventricular Arrhythmias

The Heart Rhythm Society endorsed the document.

2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design

March 5, 2012—The purpose of this expert consensus statement is to provide a state-of-the-art review of the field of catheter and surgical ablation of atrial fibrillation.

2011 HRS Policy Statement: Clinical Cardiac Electrophysiology Fellowship Curriculum

August 1, 2011—A fellowship curriculum is indispensable in the training of a clinical cardiac electrophysiologist.

2011 HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies

August 1, 2011—Genetic testing is increasingly important in determining potential cardiac conditions in patients and is used in clinical settings more than ever before.

2011 HRS/ASA Expert Consensus Statement on the Perioperative Management of Patients with Implantable Defibrillators, Pacemakers, and Arrhythmia Monitors: Facilities and Patient Management

July 1, 2011—Developed as a joint project with the American Society of Anesthesiologists (ASA) and in collaboration with the American Heart Association (AHA) and the Society of Thoracic Surgeons (S

2011 ACCF/AHA/HRS Focused Update on the Management of Patients with Atrial Fibrillation (Update on Dabigatran)

February 14, 2011—This guideline update states that dabigatran, a new antithrombotic agent that was recently approved by the U.S.

2011 ACCF/AHA/HRS Focused Update on the Management of Patients with Atrial Fibrillation (Updating the 2006 Guideline)

December 20, 2010—This guideline update focuses on several areas in which new data on management of patients with atrial fibrillation (AF) have become available, including a) recommendations for&nb

Sudden Cardiac Death Prediction and Prevention: Report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop

November 30, 2010—The National Heart, Lung, and Blood Institute (NHLBI) and the Heart Rhythm Society (HRS) jointly presented a workshop featuring experts in cardiac electrophysiology on Septem

Subscribe to